Retinal Pigment Epithelium Responses to Selective Retina Therapy in Mouse Eyes-Reference-Cited by-同舟云学术

Retinal Pigment Epithelium Responses to Selective Retina Therapy in Mouse Eyes

Published:2016-06-29 Issue:7 Volume:57 Page:3486
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Kim Hoon Dong¹,Jang Sun Young²,Lee Si Hyung³,Kim Young Shin²,Ohn Young-Hoon²,Brinkmann Ralf⁴,Park Tae Kwann⁵

Affiliation:

1. Department of Ophthalmology, College of Medicine, Soonchunhyang University, Cheonan, Republic of Korea

2. Department of Ophthalmology, College of Medicine, Soonchunhyang University, Bucheon, Republic of Korea

3. Department of Ophthalmology, Eulji University Hospital, Daejeon, Republic of Korea

4. Medical Laser Center Lübeck GmbH, Lübeck, Germany

5. Department of Ophthalmology, College of Medicine, Soonchunhyang University, Bucheon, Republic of Korea 5Laboratory for Translational Research on Retinal Macular Degeneration, College of Medicine, Soonchunhyang University, Bucheon, Republic of Korea

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing ocular protection against UVB: The role of irigenin in modulating oxidative stress and apoptotic pathways In Vivo;Biomedicine & Pharmacotherapy;2024-10

2. Suppression of choroidal neovascularization and epithelial-mesenchymal transition in retinal pigmented epithelium by adeno-associated virus-mediated overexpression of CCN5 in mice;PLOS ONE;2022-06-13

3. Factors Predicting Response to Selective Retina Therapy in Patients with Chronic Central Serous Chorioretinopathy;Journal of Clinical Medicine;2022-01-10

4. The effect of selective retina therapy for bevacizumab-resistant chronic central serous chorioretinopathy;Ophthalmologica;2021-10-14

5. The Effect of Selective Retina Therapy with Automatic Real-Time Feedback-Controlled Dosimetry for Chronic Central Serous Chorioretinopathy: A Randomized, Open-Label, Controlled Clinical Trial;Journal of Clinical Medicine;2021-09-22